Show Summary Details
Page of

NSD1 and Sotos Syndrome 

NSD1 and Sotos Syndrome
NSD1 and Sotos Syndrome

Remco Visser

and Naomichi Matsumoto

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 March 2021

Sotos syndrome (OMIM 117550) is a childhood overgrowth syndrome characterized by accelerated growth, typical craniofacial features, and a certain level of learning impairment. Sotos syndrome is caused by haploinsufficiency of the Nuclear Receptor binding SET Domain protein 1 (NSD1) gene at 5q35.2-q35.3. Genetic analysis has established insight into the spectrum of genomic abnormalities of NSD1, in the underlying mechanisms of NSD1 microdeletions and in the genotype-phenotype correlations in Sotos syndrome. Recently, the functional roles of NSD1 have also been investigated in several studies. A major role of NSD1 lies in the transcriptional regulation of chromatin through the histone methyltransferase activity of its Su(var) 3-9, Enhancer of zeste, Trithorax (SET) domain. Identification of the molecular signaling cascades linking NSD1 mutations and Sotos syndrome phenotypic characteristics remain a challenge.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.